1187313-01-4

Upstream product

• 273727-44-9 4-(4-bromo-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 57988-58-6 4-(4-bromophenyl)-4-hydroxy-piperidine 
• 1187313-18-3 C₃₁H₂₉N₅O₂ 
• 1187313-22-9 4-(6-bromopyrazolo[1,5-a]pyrimidin-3-yl)quinoline 
• 1062368-21-1 4-quinolin-4-yl-2H-pyrazol-3-ylamine 
• 1062368-20-0 C₁₄H₁₃N₃ 
• 14003-46-4 2-(quinolin-4-yl)acetonitrile 
• 91347-99-8 4-(4-bromo-phenyl)-1,2,3,6-tetrahydro-pyridine 
• 5632-17-7 4-(chloromethyl)quinoline 
• 6281-32-9 4-quinolylmethanol 
• 4363-93-3 quinoline-4-carboxaldehyde 
• 1187313-20-7 C₃₁H₃₁N₅O₂ 

Relevant academic research and scientific papers

INHIBITORS OF THE BMP SIGNALING PATHWAY

The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.